Members of the nuclear factor of activated T cells (NFAT) are involved in the induction of a number of cytokine genes. We report here cDNA cloning and chromosomal localization of a murine homologue of human NFATx, designated as mNFATxl, and its splicing variants mNFATx2 and mANFATx. Northern blot analysis showed mNFATxl to be predominantly expressed in the thymus. mNFATxl, but not mANFATx, produced in COS-7 cells, bound to all NFAT-binding sites of the interleukin (IL)-2 and IL-4 promoters tested. Immunofluorescence assay showed that both mNFATxl and mANFATx introduced into COS-7 cells localized predominantly to the cytoplasm, but did translocate to the nucleus, either by cotransfection with an active form of calcineurin or wild-type calcineurin followed by stimulation with calcium ionophore. Translocation of mNFATxl correlated well with activation of the murine IL-2 promoter; mNFATxl translocated under conditions described above, in combination with phorbol 12-myristate 13-acetate, activated the transiently transfected murine IL-2 promoter. Thus, nuclear-translocated mNFATxl is involved in activation of the IL-2 promoter. These results provide the first evidence for the requirement of calcineurin in the control of mNFATx imported from the cytoplasm to the nucleus and implies that mNFATx may possibly be a substrate of calcineurin in vivo.
INTRODUCTION
. Signals initiated by T cell receptor T lymphocytes play an important role in eliciting im-stimulation integrate on the IL-2gene promoter and mune resphoyesplay anproducingcyrokines mduring the modulate transcriptional activity. Multiple nuclear mune responses by producing cytokines durig the factors bind to and interact cooperatively on the IL-2 process of activation. Among the cytokines produced, promoter, thereby triggering gene transcription (for interleukin (IL)-2, which is expressed in a tightly reg-review, Ullman et al., 1990) . One of these sites is reculated and a tissue-specific manner, plays a crucial ognized by a protein complex called nuclear factor of role in T cell proliferation and functional activation activated T cells (NFAT; Shaw et al., 1988) , which is considered to be an important regulator in early T cell 'Corresponding author. activation. A number of other genes have NFAT-bind-ing sites in their regulatory regions and these include IL-4 (Chuvpilo et al., 1993; Szabo et al., 1993; Rooney et al., 1995a) , IL-3/GM-CSF (Masuda et al., 1993; Cockerill et al., 1995; Jenkins et al., 1995) , IL-5 (Lee et al., 1995) , tumor necrosis factor-a (Goldfeld et al., 1993; McCaffrey et al., 1994) , CD40L (Fuleihan et al., 1994) , and granzyme B (Haddad et al., 1993) . Therefore, NFAT or related factors are likely to be involved in transcriptional regulation of various genes. The NFAT complex is composed of at least two components, a cytoplasmic and a nuclear component. The nuclear component is induced by PMA and exhibits many properties indistinguishable from AP1 (Jain et al., 1992) . The cytoplasmic component resides in the cytoplasm of resting cells. Upon stimulation or activation of the cells, the cytoplasmic component translocates into the nucleus and combines with the nuclear component to constitute a functional NFAT complex. Hereafter, we refer to the cytoplasmic component as NFAT, the nuclear component as AP1, and the complex as the NFAT complex. Nuclear localization of NFAT usually occurs within minutes of cellular stimulation in a cyclosporin A (CsA)-and FK506-sensitive manner and does not require protein synthesis (Karen et al., 1995) . Calcineurin (CaN),1 a calcium/ calmodulin-dependent serine/threonine phosphatase, plays a crucial role in the calcium-regulated pathway of T cell activation. Overexpression of CaN in T cell lines partially overcomes the requirement of calcium entry for activation (Clipstone and Crabtree, 1992; Woodrow et al., 1993) . It has also been shown that CaN can dephosphorylate one of the members of the NFAT family, namely, NFATp, and this dephosphorylation is an early step in the activation of NFATp that is a prerequisite for the translocation (Karen, et al., 1995) . Immunosuppressive drugs such as CsA and FK506 bind to intracellular receptors, and by inhibiting the catalytic activity of phosphatase CaN, block the translocation of NFAT (for review, Bierer, 1994) . On the other hand, induction of AP1 family proteins is dependent on the protein kinase C (PKC)/Ras pathway and is insensitive to CsA and FK506. Taken together, the mechanism for formation of a functional NFAT complex indicates that T cell activation signals diverged by activating PKC and intracellular calcium influx converge at the NFAT-binding sites, and gene transcription is modulated.
The NFAT-binding sites consist of two highly conserved motifs: a purine-rich segment and an APlbinding site-like motif. AP1 interacts with NFAT at the 'Abbreviations used: CaN, calcineurin; CNAA, constitutive active form of calcineurin; CNA and CNB, subunits of wild-type calcineurin; EMSA, electrophoretic mobility shift assay; FISH, fluorescence in situ hybridization; IL, interleukin; NFAT, nuclear factor of activated T cells; PKC, protein kinase C; PMA, phorbol 12-myristate 13-acetate; RT, reverse transcription.
composite NFAT-binding elements and stabilizes the binding of NFAT to DNA (Jain et al., 1993) . It has also been demonstrated that dephosphorylation of NFAT increases its DNA-binding affinity (Karen, et al., 1995; Park et al., 1995) .
Molecular cloning has revealed that the NFAT family is composed of at least four members (NFATp, NFATc, NFATx/4, and NFAT3; McCaffrey et al., 1993; Northrop et al., 1994; Hoey et al., 1995; Masuda et al., 1995) , which are products of distinct genes. Characterization of these gene products demonstrated that these proteins all contain a conserved 300-amino acid region Northrop et al., 1994; Hoey et al., 1995; Masuda et al., 1995) , which is distantly related to Rel domains of NFKB proteins (Nolan, 1994) , and is also involved in NFAT DNA binding and cooperatively interacts with AP1 Hoey et al., 1995; Jain et al., 1995) . Among the NFAT family members, a human cDNA encoding NFATx (hNFATx) has been isolated from Jurkat T cell lines and is expressed highly in the thymus . High abundance in the thymus means that this protein is probably involved in T cell development as well as in controlling expression of cytokine genes. To obtain support for our proposals, we isolated cDNA clones that encode the murine homologue of hNFATx and its splicing variants. We report here functional characterization of mNFATx and that mNFATx transports into the nucleus in response to CaN-mediated signaling.
MATERIALS AND METHODS Cell Culture
EL-4 cell lines were cultured in RPMI 1640 supplemented with 5% fetal calf serum (FCS), 2 mM L-glutamine, 50 ,M 2-mercaptoethanol, 50 U/ml penicillin, and 50 jig/ml streptomycin. COS-7 cells were grown in DMEM containing 10% FCS, 50 U/ml penicillin, and 50 ,ug/ml streptomycin.
cDNA Cloning and Sequencing Poly(A)+ RNA was isolated from unstimulated EL-4 cells using the FastTrack mRNA Isolation kit (Invitrogen, San Diego, CA). From 5 j,g of Poly(A)+ RNA, oligo(dT)-primed cDNA library was constructed using the ZAP-cDNA Synthesis kit (Stratagene, Cambridge, United Kingdom) according to the manufacturer's protocol. The cDNA was size-selected by electrophoresis on a 0.8% agarose gel to enrich the population larger than 1 kb prior to ligation. The resulting library contained approximately 9.5 x 107 independent plaques per ,ug of RNA and an average insert size of 2.1 kb (range, 1.3-3.0 kb).
A 2.8-kb fragment from the human NFATx cDNA, which includes the Rel homology domain , was used as a probe for the initial library screening at low stringency. A partial cDNA from the positive clones was then used for additional screening at high stringency. DNA sequence was determined using a Taq DyeDeoxy Terminator Cycle Sequencing kit and a Taq Dye Primer Cycle Sequencing kit (ABI, Columbia, MD). The samples were analyzed using the Applied Biosystem model 373A DNA Sequencing System (ABI). The entire sequence was confirmed by sequencing both strands.
Molecular Biology of the Cell Cloning and Characterization of Murine NFATx
The 5' end of the cDNA was obtained by polymerase chain reaction (PCR) using 100 ng of random-primed cDNA generated from mRNA of unstimulated EL-4 cells as described by suppliers (Amersham, Arlington Heights, IL). The sense primer, 5' AGCTT-TCGGAACGGAACGCT 3', was derived from the hNFATx sequence (Masuda, unpublished data) . The antisense primer, 5' GCT-CAGCCAATTCTCATCAG 3', was derived from the mNFATxl sequence 775-756 as shown in Figure 1A . (Tokunaga et al., 1986) . Electrophoresis, RNA blotting, random labeling of the probe, and hybridization were performed according to standard procedures (Sambrook et al., 1989) .
Reverse Transcription (RT)-dependent PCR
Total RNA purification and RT-PCR were done essentially as described previously (Sambrook et al., 1989 (Hori et al., 1990) . Mouse chromosome DNA was prepared according to Matsuda et al. (1992) . Hybridization conditions, probe detection, and analysis of the bands and signals were done as described previously .
Plasmid Constructions and Transfection of COS-7 Cells
For construction of pME-mNFATx1 and pME-mANFATx expression vectors, the full length of either mNFATxl or mANFATx cDNA was subcloned into the downstream of the SRca promoter of the pME18S vector (Kitamura et al., 1991) by replacing an EcoRI-XhoI fragment. Expression plasmids for constitutive active CaN (pBJ5-CNAA) and wild-type CaN (pBJ5-CNA and pBJ5-CNB) were kindly provided by A. Tsuboi . The reporter plasmid pmoIL-2-32lLuc was described previously (Tsuruta et al., 1995) .
Transfection of COS-7 cells was done using a DEAE-dextran procedure. Briefly, for each transfection, the medium was changed to 4 ml of serum-free medium containing 5 jig of DNA, 500 ,ug/ml DEAE-dextran, and 50 mM Tris-HCl. After a 2-h incubation, the medium was aspirated, and the cells were treated for 1 min with 1 ml of 20% glycerol. Subsequently, the cells were washed twice with PBS and cultured in 5 ml of DMEM with 10% FCS. At 70 h after transfection, the cells were either unstimulated or stimulated for 6 h with PMA (20 ng/ml) and ionomycin (0.5 pLM) and harvested for preparation of cell extracts.
For luciferase assays, COS-7 cells were transfected with 6 jig of pmoIL-2-32lLuc reporter plasmid and 6 jig each of pME18S, pMEmNFATxl, pBJ5-CNAA, or pBJ5-CNA plus pBJ5-CNB plasmids. pME18S was used to adjust the total amount of DNA transfected, as required. Transfected cells were either not stimulated or were stimulated with PMA (20 ng/ml) or A23185 (0.5 jiM) alone, or PMA plus A23187 for 8 h. Luciferase activity was measured using the Luciferase Assay System (Promega, Madison, WI). Relative luciferase unit was normalized to the protein concentration estimated by the BCA protein assay reagent (Pierce, Rockford, IL). Each transfection was repeated at least three times.
Electrophoretic Mobility Shift Assay (EMSA)
For EMSA, nuclear extracts were made from unstimulated or stimulated COS-7 cells as described previously (Watanabe et al., 1993) . EMSA was performed as described (Masuda et al., 1993) . The sequences of the synthetic oligonucleotides used were as follows (only one strand is shown; mutation and 5' overhangs are presented in lower case): distal NFAT site of the murine IL-2 promoter, 5'-gatcCAAA-GAGGAAAATTTGTTTCATACAGAAGGCGTTCA-3'; 45 NFAT site of the murine IL-2 promoter, 5'-ctagaCACCCCCATATTAT'TTYCCAGCATTa-3'; 90 NFAT site of the murine IL-2 promoter, 5'-ctagaCTCTTTTGAAAATATGTGTAATATGTAAAACATa-3'; 135 NFAT site of the murine IL-2 promoter, 5'-gaTCAGAAGAGGAAAAA-CAAAGGTAATGCGA-3'; 160 NFAT site of the murine IL-2 promoter, 5'-ctagaAAAGAAATFCCAGAGAGTCATCAGAAa-3'; and the murine IL4 P element, 5'-caITGGAAAATTTTfATTACACCAGA-3'.
In the competition experiments, the following oligonucleotides were used (lower case letters in the middle of the oligonucleotides refer to mutations): AP1 consensus sequence 5'-ggCGCTTGAT-GAGTCAGCGGAA-3'; SP1 site 5'-ggATTCGATCGGGGCGGGGC-GAGC-3'; mutant murine IL-4 P element 5'-caTTGtcgAcTTT-TATTACACCAGA-3'; and mutant murine NFAT site 5'-AAGAGtcgAcTTTGITfCATACAGAAGGcg-3'.
Immunofluorescence Staining
For immunocytochemistry, the transfected COS-7 cells were either not stimulated or were stimulated with A23187 (0.5 jiM) for 2 h, and the cells were fixed with 3.7% formaldehyde at room temperature. mNFATx was stained with an affinity-purified polyclonal antibody APaDS raised against a bacterially produced recombinant peptide of human NFATx extending from amino acid residues 387-728 . The secondary antibody was fluorescein isothiocyanate (FITC)-labeled goat anti-rabbit IgG (ZYMED).
RESULTS

Molecular Cloning of Murine NFATx and Its Variants
Based on our previous observation that the mRNA level of hNFATx was not significantly affected by exposure of human Jurkat cells to calcium ionophore and phorbol ester , mRNA from unstimulated EL-4 cells was used for the construction stringency using the 2.8-kb fragment of hNFATx. Two of a cDNA library. Primary screening was done at low positive clones were obtained out of 1 X 106 indepenMolecular Biology of the Cell dent plaques. The sequenced 5' and 3' ends of each clone proved to have a close identity with hNFATx. The longer clone containing about 2.2 kb of insert was then used as a probe, and the same library was screened under high stringency conditions. From this screening, six additional overlapping clones were obtained. Sequence analysis demonstrated a high degree of homology to human NFATx, thereby suggesting that they are the murine homologues of hNFATx. The clone containing the longest cDNA insert comprised 3086 nucleotides, from nucleotides 571 to 3656 in Figure 1A , but lacked the in-frame ATG codon. To obtain the complete 5' sequence of mNFATx cDNA, we designed a sense primer based on the 5' uncoding region of hNFATx (175 bases upstream of the first in-frame ATG codon; Masuda, unpublished data) and an antisense primer derived from the mNFATx cDNA for use in PCR. Three independent recombinant clones from separate amplification reactions were sequenced and gave identical sequences. The obtained region showed approximately a 99.3% identity to the hNFATx sequence and included an in-frame ATG codon. Thus, we reconstituted the full cDNA sequence of mNFATx by assembling the 5' end of cDNA obtained by PCR and a cDNA clone isolated from a library.
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The nucleotide sequence of mNFATx cDNA, designated as mNFATxl in Figure 1A , has 3656 nucleotides and a predicted open reading frame of 1075 amino acids with a deduced molecular weight of 119 kDa. There was a 95, 98, and 76% amino acid identity with hNFATx in the N-terminal, Rel homology domain, and C-terminal portions, respectively, as shown in Figure 1B . The N-terminal part with the high homology contained a 410-amino acid region, with repetitive sequences of SPXXSPXXSPXXXXX(D/E),(D/E), termed SP boxes . SP boxes are strictly conserved among NFATx, NFATc, and NFATp. Their functions remain to be elucidated. The middle part of the molecule with the highest homology to hNFATx contained the Rel homology domain. The most notable within this 289-amino acid region was the presence of positively charged residues, such as aspartate or glutamate, which are thought to be important for DNA binding (Liou and Baltimore, 1993) . In addition, a putative nuclear localization signal sequence KRKK was present at the carboxy terminus of the Rel homology region of mNFATxl. Within the Rel homology domain, mNFATxl displayed a 67-70% identity to sequences of other members of the NFAT family, including murine NFATp (67% identical), human NFATc (70% identical), and human NFAT3 (70% identical).
Of the cDNAs isolated, two alternatively spliced isoforms were identified, one showed a difference in the 3'-coding region with a 104-bp insert, resulting in a frame shift and replacement of 41 amino acids of mNFATxl with a distinct 33-amino acid sequence.
Another splicing variant had an in-frame 30-amino acid deletion in its Rel homology domain. Interestingly, corresponding variants were also isolated from human Jurkat T cell lines (Imamura and Masuda, unpublished data). mNFATx2 was also similar to human NFAT4c that has been reported by Hoey et al. (1995) throughout the entire molecule, thus it may be the murine homologue of human NFAT4c. Here, we refer to the most abundant clone as mNFATxl, one with a different sequence in the C-terminus as mNFATx2, and one with deletion as mANFATx, respectively, in correlation with the variants of hNFATx clones (Figure 1C ). mNFATxl and mANFATx were then characterized.
Northern Blot Analysis of mNFATx Northern blot analysis was carried out using poly(A)+ RNA from various mouse tissues (Figure 2 ). The size of the major hybridizing band was approximately 7.5 kb. The transcript of mNFATxl was abundant in the thymus, which is also the case with hNFATx . Expression was lower in testis, ovary, heart, and skeletal muscles. These results were confirmed by using total RNAs from multiple mouse tissues (our unpublished data). To examine the binding activity of mNFATxl and mANFATx by EMSA, we transfected pME-mNFATx1 and pME-mANFATx into COS-7 cells and prepared nuclear extracts from each sample. Expression levels of mNFATxl and mANFATx in the nuclear extracts were equivalent, as judged by Western blot analysis. We also transfected pME-hNFATx for comparison and the vector pME18S as a control. When we used the distal NFAT-binding site (-280 site) of the murine IL-2 promoter, two inducible complexes were observed in the nuclear extracts of stimulated cells that had been transfected with pME-mNFATxl or pME-hNFATx ( Figure 5A , lanes 4 and 2, respectively). The intensity of the lower complex was weaker than that of the upper complex. Both the upper and the lower complexes were efficiently and specifically competed by a 50-fold excess of unlabeled NFAT oligonucleotides (self; Figure 5A , lane 5), but was unaffected by the mutated NFAT or unrelated oligonucleotides carrying the SP1 binding site (our unpublished data). An excess of unlabeled AP1 probes completely inhibited only the upper complex and had no effect on formation of the lower complex ( Figure  5A Molecular Biology of the Cell tained mNFATxl, whereas the upper complex contained both mNFATxl and AP1. In contrast to mNFATxl, mANFATx failed to form a complex with the distal NFAT-binding site, under identical conditions, and the pattern of the bands was comparable to that observed from the nuclear extracts of the cells transfected with the empty expression vector ( Figure 5A , compare lanes 7 and 8 with lanes 9 and 10). A similar pattern was obtained in experiments using as a probe the proximal NFAT-binding site of the mouse IL-2 promoter (-135 site; data not shown).
Four NFAT-binding sites have been noted within the IL-4 promoter. The binding of NFAT to these sites was shown to be essential for promoter activity (Chuvpilo et al., 1993; Szabo et al., 1993; Rooney et al., 1995; Weiss et al., 1996) . Using a radiolabeled oligonucleotide spanning the P element, which shares sequence similarity with NFAT-binding sites (Abe et al., 1992; Matsuda, et al., 1994) , we detected two specific DNAprotein complexes. However, in this case, the lower complex was formed at a higher intensity than the upper complex ( Figure 5B , lanes 5 and 6). The upper complex appeared in the nuclear extract of cells transfected with pME-mNFATxl after stimulation and was completely inhibited by a 50-fold excess of oligonucleotides corresponding to either the P element (self) or the AP1 sequence ( Figure 5B , lanes 7 and 8), whereas the lower complex was not competed by AP1 ( Figure  5B , lane 8). Similar results were obtained with nuclear extracts of cells transfected with pME-hNFATx (Figure 5B, lanes 1-4) . Binding of mANFATx to the P sequence was not detected as was the case with the IL-2 distal NFAT site ( Figure 5B, lanes 9 and 10) . The mNFATxl-containing bands observed in the unstimu- Figure 5 . DNA-binding activity of mNFATx to NFAT-binding sites in the IL-2 and IL-4 promoters. (A) The distal NFAT site of murine IL-2 promoter (-280 site) was used as a probe. EMSAs were carried out with nuclear extracts from COS-7 cells transfected with pME-hNFATx (lanes 1 and 2), pME-mNFATxl (lanes 3-6), pMEmANFATx (lanes 7 and 8), or pME18S (mock, lanes 9 and 10). The transfected cells were either not treated (lanes 1, 3, 7, and 9) or treated with 20 ng/ml PMA and 0.5 ,uM ionomycin (P/I) for 6 h (lanes 2, 4-6, 8, and 10). Competition experiments were done in the presence of a 50-fold M excess of unlabeled oligonucleotides corresponding to the mouse IL-2 distal NFAT-binding site (lane 5) and the AP1 site (lane 6), respectively. The positions of the two specific protein-DNA complexes (upper and lower) and of the unlabeled probe are indicated by arrows. (B) The P element of the mouse IL-4 promoter was used as a probe in EMSA using the same nuclear extracts as used in A. A 50-fold excess of unlabeled oligonucleotides corresponding to the P element (lanes 4 and 7) and AP1 site (lanes 3 and 8) was used as competitors. The specific complexes detected are indicated by arrows. (C) EMSAs were performed using NFATbinding sites at positions -45, -90, and -160 of the mouse IL-2 promoter. The nuclear extracts were isolated from stimulated COS-7 cells, which were transfected with pME-mNFATx1. Arrows lated nuclear extracts may be due to leakage of the overexpressed molecules from the cytoplasmic extracts.
NFAT was originally reported to bind two sites (the distal NFAT site at -280 and the proximal NFAT site at -135) in the IL-2 promoter, in association with AP1. Recently, three additional NFAT-binding sites (-45, -90, and -160) were identified, and all five NFAT sites are apparently critical for induction of IL-2 promoter activity (Rooney et al., 1995b) . To compare the binding ability of mNFATxl to these sites, EMSA was performed using each of these elements as a probe ( Figure 5C ). mNFATxl bound to the -45 site, independent of AP1, as judged by competition with unlabeled oligonucleotides containing the murine IL-2 distal NFAT site and the AP1 sequence. Three nuclear complexes were detected using the -90 site as a probe. Addition of the unlabeled oligonucleotide of the distal NFAT-binding site eliminated formation of the upper complex, whereas the unlabeled AP1 oligonucleotide could inhibit formation of the upper and middle bands, suggesting that the upper complex was composed of at least mNFATxl and AP1. A previous report has shown that the middle complex contains OCT1 and AP1, whereas the lower complex contains OCT1 (Rooney et al., 1995b) . Further examination using the OCT1 recognition sequence as a competitor is required to test the nature of these two complexes. Two nuclear complexes were observed using as a probe the -160 site. Addition of the unlabeled distal NFAT site oligonucleotide abolished formation of the upper but not lower complex. In contrast, with unlabeled AP1 oligonucleotides, detection of both of the two complexes was reduced, indicating that the upper complex contained mNFATxl in association with AP1, whereas the lower nuclear complex may represent an APl-binding complex lacking NFAT. Activated CaN Translocates mNFATx to the Nucleus To determine whether mNFATx can translocate into the nucleus, we transiently transfected pME-mNFATxl and pME-mANFATx into COS-7 cells, and immunofluorescence staining assays were done. Both mNFATxl and mANFATx were predominantly localized to the cytoplasm in unstimulated cells. Treatment with A23187 had no significant effect on the distribution of mNFATxl and mANFATx ( Figure 6A-D) . Since mNFATxl and mANFATx were overexpressed in COS-7 cells, we assumed that the lack of nuclear staining may be due to a lower level of CaN to transmit the calcium signal. Therefore, we cotransfected either pME-mNFATxl or pME-mANFATx in combination with equal amounts of an expression vector encoding the constitutively active form of CaN (pBJ5-CNAA) in COS-7 cells. As can be seen in Figure 6 , E and F, expression of CNAA induced translocation of both mNFATxl and mANFATx to the nucleus without further treatment with A23187. However, in some cells, mNFATxl or mANFATx located predominantly in the cytoplasm. When we increased the amount of transfected pBJ5-CNAA, the proportion of cells that mNFATxl or mANFATx had translocated was increased (our unpublished data). Thus, the potential of mNFATxl and mANFATx to translocate into the nucleus correlated with the presence of constitutively active CaN. Expression of CNAA partially bypassed the calcium requirement for NFAT translocation. To check whether the translocation depends on the activity of CaN, we cotransfected expression vectors encoding the catalytic CNA and regulatory CNB subunits of wild-type CaN (pBJ5-CNA and pBJ5-CNB, respectively) along with either pME-mNFATxl or pMEmANFATx into COS-7 cells and tried to activate CaN by stimulation with A23187. As expected, only the cytoplasm was stained in unstimulated cells ( Figure 6 , G and H). When we stimulated the cells with A23187, the localization of mNFATx to the nuclei was induced dramatically (Figure 6 , I and J). We also did the same assay by cotransfecting pBJ5-CNAA and pME18S vectors as a control. Neither cytoplasmic nor nuclear staining was detected ( Figure 6K ). The activated CaN apparently could trigger translocation of mNFATx from the cytoplasm into the nucleus.
mNFATxl Can Activate Transcription of the Murine IL-2 Promoter in COS-7 Cells With evidence that mNFATx can translocate into the nucleus, depending on the activity of CaN, and that mNFATxl expressed in COS-7 cells was capable of binding to the NFAT sites of the IL-2 and IL-4 promoters, we next asked whether mNFATxl could activate in COS-7 cells transcription driven by the murine IL-2 promoter. As shown in Figure 7 , transfection of pME-mNFATxl alone had no significant effect on the IL-2 promoter in the absence of stimulation. The promoter was activated threefold after stimulation with PMA and A23187 in the presence of pME-mNFATx1. When we cotransfected pBJ5-CNA and pBJ5-CNB with pME-mNFATx1, the exogenous IL-2 promoter transcription was increased sixfold over that of mock transfection, and the addition of either PMA or A23187 did not alter the activity. However, when the transfected cells were treated with both PMA and A23187, the transcription activity was further enhanced by 6.3-fold. When we cotransfected pBJ5-CNAA with pME-mNFATxl, the IL-2 promoter activity was increased by approximately fivefold after treatment of the cells with PMA alone, suggesting that overexpression of CNAA could partially replace the calcium-mediated signaling and act in synergy with PMA to stimulate mNFATxl-dependent transcription.
The effects of CaN were not observed when the empty vector (pME18S) was transfected instead of pME-mNFATx1. Therefore, mNFATxl translocated to the nucleus by activated CaN had the potential to enhance transcription from the IL-2 promoter in combination with the PMA-mediated signaling.
DISCUSSION
We report here the full-length cDNA cloning of a novel member of the murine NFAT family. This clone shares high sequence identity with hNFATx and also homology with other NFAT family members, namely, mNFATp, hNFATc, and hNFAT3 within the Rel homology domain. Thus, we concluded that the clone we obtained was the murine counterpart of human NFATx. Of the clones isolated, we obtained three types of mNFATx, designated as mNFATxl, mNFATx2, and mANFATx. These differences may be due to alternative splicing, since the corresponding splicing variants were cloned from human T cells (Imamura and Masuda, unpublished data; Hoey et al., 1995) . mNFATxl had the identical sequence, except for the first 23 amino acids in its N-terminal portion to a recently reported clone NFATc3 that encodes a partial sequence for a NFAT family member, suggesting that NFATc3 is one of the splice variants of the clones we isolated. We obtained an in-frame ATG codon that was not present in NFATc3. Chromosome mapping showed that the gene for mNFATx is located on mouse chromosome 8 band D. This region is syntenic with human 16q 21 -> 22 where hNFATx had been mapped . The identical region was mapped using two different probes specific to mNFATxl and mNFATx2. Moreover, NFATc3 has been mapped in mouse chromosome 8 (Ho et al., 1995) . These results support the notion that these clones are different splicing isoforms of mNFATx and derived from a single gene. mNFATxl was expressed predominantly in thymus and weakly in muscles, spleen, and kidney (Figure 2 ). Thus, mNFATxl may be involved in T cell development as well as regulating cytokine gene expression in T cells. The transcript of mNFATxl was constitutively expressed in EL-4 cells and was not induced by treatment with PMA. In addition, mNFATxl mRNA was also constitutively expressed in both Thl and Th2 T cell clones, D1.1 and D10, respectively (Naito, unpublished observation). The amount of mANFATx mRNA did not vary and the ratio of mNFATxl to mANFATx remained constant (Figure 3 ). The functional significance of mNFATxl, mNFATx2, and mANFATx remains to be clarified. Northern blotting using specific probes of different variants may provide clues for such studies.
Our results and data from other groups of workers have shown that the NFAT family members are expressed with distinct tissue specificity (Hoey et al., 1995; Masuda et al., 1995; Wang et al., 1995) . Moreover, induction kinetics of NFAT family members differ; NFATx and NFATp are constitutively expressed, whereas NFATc is induced by the activation of PKC/ Ras pathway and/or calcium mobilization. These differential patterns of expression and cellular distribution may at least, in part, reflect the unique targets and functions of each of the NFAT family members. It is of particular interest to investigate the cooperation and/or the specific role of NFAT members, including the specific target sequences and the promoters they regulate in the immune system.
EMSA showed that mNFATxl can bind to the distal NFAT-binding site of the murine IL-2 promoter and the P element of the IL-4 promoter either alone or in combination with AP1 ( Figure 5,A and B) . Comparing the densities of the inducible lower complexes formed with these two probes (compare Figure 5A , lane 4 with Figure 5B , lane 6), it seems that the binding of mNFATxl to the murine IL-2 distal NFAT site depended more on the presence of AP1 than the murine IL-4 P element. The binding of mNFATxl to murine IL-2 and IL-4 promoters may have different requirements and/or the binding affinity for AP1 components. This hypothesis was also supported by the results using cytosolic extracts in EMSA; when we used cytoplasmic extract from unstimulated pME-mNFATxl-transfected cells, which should contain no or little, if any, AP1 components, NFAT binding was detected with the P element, but none was detected with the distal IL-2 NFAT binding site (our unpublished results). Another example is from our binding assays using different NFAT-binding sites located in the IL-2 promoter; mNFATxl could associate with AP1 to bind to all NFAT-binding sites, except -45 IL-2 NFAT-binding site. These differences in binding affinities and requirements for associating factors may explain why cytokine genes are expressed in a pattern distinct from each other, although many do have in common NFAT-binding sites in their promoters.
Lower complexes formed in the nuclear extracts of the cells treated with PMA/ionomycin migrated slightly faster than those formed in the nuclear extracts of untreated cells ( Figure 5, A and B) . It is likely that this small change in mobility is due to a modification of mNFATxl by endogenous CaN.
Although mANFATx contained an intact RA-HYETEG sequence, which is implicated in the DNAbinding activity of NFATp , it failed to bind to the murine IL-2 and IL-4 NFAT-binding sites to form both the upper and the lower complexes. The lack of DNA-binding activity of mANFATx was not due to a lower level of nuclear translocation; when we measured binding activity to the P element using a cytosolic extract prepared from unstimulated cells that had been transfected with pME-mANFATx, DNA -A23187 -CaN +A23187 -CaN Figure 6 . Effects of CaN on mNFATx nuclear localization. pME-mNFATxl (A, C, E, G, and I), pME-mANFATx (B, D, F, H, and J), and pME18S (mock con--A23187 trol, K) were either transfected Interestingly, when we coexpressed CNA and CNB with mNFATx and stimulated with A23187, the number of the cells in which mNFATx had translocated to the nuclei was approximately 1.5-fold over that of cells cotransfected with CNAA and mNFATx, without A23187 stimulation. In agreement with this result, transcriptional activity of the IL-2 promoter was higher in cells transfected with the two subunits of CaN followed by stimulation with PMA and A23187 than in the cells cotransfected with the constitutively active form of CaN in the presence of PMA alone. Figure 7 . Coexpression of CaN with mNFATxl activates the transiently transfected murine IL-2 promoter in COS-7 cells. IL-2 reporter plasmid and pME18S or pME-mNFATxl were cotransfected either alone or in combination with pBJ5-CNAA or pBJ5-CNA and pBJ5-CNB into COS-7 cells. The transfected cells were either not stimulated or stimulated for 8 h with either PMA or A23187 alone, or the combination of PMA and A23187 at 70 h after transfection. Relative luciferase unit was measured as described in MATERIALS AND METHODS.
These observations are consistent with studies showing that cotransfection of the two CaN subunits is essential for efficient CaN expression in mammalian cells (Shibasaki and Mckeon, 1995) and that CNB can stabilize CNA, probably by protecting CNA from proteolytic degradation in the cells (Milan et al., 1994) . Translocation of mNFATxl showed a good correlation with activation of the IL-2 promoter. Transiently expressed mNFATxl also augmented threefold transcription of the IL-2 promoter in the presence of PMA and A23187. This activation may be due to translocation of the transfected mNFATxl to the nucleus by activation of endogenous CaN and in combination with endogenous AP1. The translocated molecules seemed to be only a small proportion, since we did not observe obvious translocation of mNFATx in the immunostaining assay under identical conditions. When activated CaN molecules were obtained either by 1) transfection with the active form of CaN or 2) transfection with CNA and CNB plus treatment with calcium ionophore, the transcriptional activity of the IL-2 promoter was greatly enhanced. The correlation between immunostaining and reporter gene assays suggests that mNFATxl translocated to the nucleus may contribute to transcription of the IL-2 gene.
Our observations show the two-signal requirement for transcriptional activation of the IL-2 promoter. Introduction of the active form of CaN plus mNFATxl localizes mNFATxl to the nucleus in the absence of A23187 (Figure 6 ). Under this condition, the IL-2 promoter was activated by PMA alone and was not affected dramatically by the addition of A23187 (our unpublished result). When we introduced CNA and CNB, which requires calcium ionophore for activation, the promoter was activated only when transfected cells were stimulated with both PMA and A23187. Thus, the IL-2 promoter requires two signals, those initiated by calcium influx and by activation of PKC activity in COS-7 cells, and that the calcium-mediated signal can, at least in this system, be by assed by supplying activated CaN and mNFATxl. Ca +-dependent mechanisms other than the CaN-mediated pathway may regulate transcriptional activation of the IL-2 promoter, as is the case in other systems (Hama et al., 1995) .
We do not know whether CaN directly interacts and aids mNFATx in moving into the nucleus or indirectly regulates its subcellular localization by operating on cytoplasmic proteins such as anchor proteins that carry out the nuclear import of NFAT. Mutation analyses of mNFATx will need to be done to test these possibilities and to find the target sequence of CaN on mNFATx.
Our finding that mNFATx can be regulated by CaN and that NFATx is expressed highly in the thymus has important implications. CaN translocates NFAT to the nucleus, and CsA and FK506, which inhibit the activity of CaN, can block the transcription activity driven by NFAT. On the other hand, some studies revealed that CsA and FK506 are involved in T cell receptormediated apoptosis (Shi et al., 1989; Bierer et al., 1990; Fruman et al., 1992; Urdahl et al., 1992) and thymocyte development (Gao et al., 1988; Fukuzawa et al., 1989; Takeuchi et al., 1990) . Although the function of CaN in thymocyte development is not clear, all of this evidence suggests the possibility that activation of NFAT may be involved in these processes. Additional studies to identify downstream targets of CaN are expected to reveal the significance of calcium signaling and the biological role of NFAT.
